Chemical Dependency and Smoking Cessation: Patient's Views - 1

Tobacco Use Disorder Clinical Trial

Official title:

Chemical Dependency and Smoking Cessation: Patient's Views

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00051883
• Other study ID #: NIDA-00450-1
• Secondary ID: K01-00450-1
• Status: Completed
• Phase: Phase 4
• First received: January 17, 2003
• Last updated: January 11, 2017
• Start date: December 1999
• Est. completion date: February 2005

Study information

• Verified date: October 2016
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to asses patient views on smoking cessation and tobacco harm reduction during drug treatment.

Description:

Participants included 34 patients who had never voluntarily quit smoking for longer than 24 hours (continuous smokers), 34 smokers who had quit smoking for at least 24 hours before but had relapsed (relapsers), and 10 former smokers who had been abstinent for at least the past 6 months (successful quitters). We held 7 focus groups, 3 with continuous smokers and 4 with relapsers. Focus groups lasted 2 hours and were held at participants' clinics to preserve confidentiality. We conducted hour-long individual interviews with successful quitters. All participants completed a brief written survey immediately before their session. Survey items included questions on demographics, smoking behaviors, and motivation for cessation, reduction, and nicotine maintenance. We reimbursed all participants $40 and provided a meal to focus group attendees.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 125
• Est. completion date: February 2005
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

Selection criteria included being 18 years or older, smoking 5 or more cigarettes per day for at least 2 years, and being enrolled continuously in methadone maintenance treatment (MMT) for at least the past 2 years.

Exclusion Criteria:

Being less than 18 years of age, smoking 4 or fewer cigarettes per day, smoking less than daily for less than 2 years, and not being enrolled continuously in methadone treatment for at least the 2 past years.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Tobacco Use Disorder

Locations

Country	Name	City	State
United States	University of Kansas Medical Center	Kansas City	Kansas

Sponsors (1)

Lead Sponsor	Collaborator
National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States,